Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

31.43
Delayed Data
As of Aug 23
 -0.37 / -1.16%
Today’s Change
14.84
Today|||52-Week Range
36.11
+1.49%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close31.80
Today’s open31.70
Day’s range31.35 - 31.94
Volume189,895
Average volume (3 months)271,905
Market cap$1.1B
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)+55.00%
Earnings growth (this year)-114.80%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.00%
P/E ratioNM
Price/Sales9.77
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.51+2.29%
PTLAPortola Pharmaceutic...+0.83+4.32%
EBSEmergent BioSolution...-0.14-0.50%
RGENRepligen Corp-0.10-0.31%
Data as of 08/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$100.9M
Annual profit (last year)-$20.1M
Net profit margin-19.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers

Search for Jobs